Zobrazeno 1 - 10
of 359
pro vyhledávání: '"Haakensen VD"'
Autor:
Thunold S; Dept of Oncology, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. solthu@ous-hf.no., Hernes E; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Farooqi S; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Öjlert ÅK; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Francis RJ; Dept of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Australia.; Medical School of The University of Western Australia, Perth, Australia., Nowak AK; Medical School of The University of Western Australia, Perth, Australia.; National Centre for Asbestos-Related Diseases, University of Western Australia, Perth, Australia.; Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia., Szejniuk WM; Clinical Cancer Research Center & Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Nielsen SS; Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark., Cedres S; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Perdigo MS; Dept of Nuclear Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Meltzer C; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Mikalsen LTG; Department of Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.; Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway., Helland Å; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Malinen E; Dept of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Physics, University of Oslo, Oslo, Norway., Haakensen VD; Dept of Oncology, Oslo University Hospital, Oslo, Norway.; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug 12. Date of Electronic Publication: 2024 Aug 12.
Autor:
Nymoen HM; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Alver TN; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway., Horndalsveen H; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Eide HA; Department of Oncology, Oslo University Hospital, Oslo, Norway., Bjaanæs MM; Department of Oncology, Oslo University Hospital, Oslo, Norway., Brustugun OT; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Oncology, Drammen Hospital, Vestre Viken Health Trust, Drammen, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Haakensen VD; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Helland Å; Institute for Cancer Research, Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Aug 01; Vol. 14, pp. 1412716. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).
Autor:
Filippi AR; Radiation Oncology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy. Electronic address: andreariccardo.filippi@istitutotumori.mi.it., Bar J; Institute of Oncology, Sheba Medical Centre, Ramat Gan; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chouaid C; Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France., Christoph DC; Department of Medical Oncology, Evang. Kliniken Essen-Mitte, Evang. Huyssens-Stiftung Essen-Huttrop, Essen, Germany., Field JK; Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK., Fietkau R; Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany., Garassino MC; Department of Hematology/Oncology, The University of Chicago, Chicago, USA., Garrido P; Medical Oncology Department, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain., Haakensen VD; Department of Oncology and Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Kao S; Chris O'Brien Lifehouse, Sydney., Markman B; Cabrini Hospital and Monash University, Melbourne, Australia., McDonald F; Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK., Mornex F; Department of Radiation Oncology, Centre Hospitalier Universitaire de Lyon, Lyon, France., Moskovitz M; Rambam Health Care Campus, Haifa, Israel., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Sibille A; Department of Pneumology, Centre Hospitalier Universitaire de Liège, Liège, Belgium., Siva S; Peter MacCallum Cancer Centre and The University of Melbourne, Melbourne, Australia., van den Heuvel M; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Vercauter P; Department of Pneumology, OLV Hospital Aalst, Aalst, Belgium., Anand S; AstraZeneca, Gaithersburg, USA., Chander P; AstraZeneca, Gaithersburg, USA., Licour M; AstraZeneca, Courbevoie, France., de Lima AR; AstraZeneca, Gaithersburg, USA., Qiao Y; AstraZeneca, Gaithersburg, USA., Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris; UVSQ, Paris Saclay, Versailles, France.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103464. Date of Electronic Publication: 2024 Jun 03.
Autor:
Gullhaug A; Department of Life Sciences and Health, Oslo Metropolitan University, Faculty of Health Sciences, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: Anna.Gullhaug@oslomet.no., Haakensen VD; Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., De Ruysscher D; Department of Radiation Oncology (Maastro), Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, the Netherlands., Simone CB 2nd; New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, New York, USA., Hotca-Cho AE; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Chhabra AM; New York Proton Center, New York, New York, USA., Hellebust TP; Department of Medical Physics, Oslo University Hospital, Oslo, Norway; Department of Physics, University of Oslo, Oslo, Norway., Paulsen EE; Department of Clinical Medicine, UiT, The Arctic University of Norway, Tromso, Norway; Department of Oncology, University Hospital of North Norway, Tromso, Norway., Dimopoulos MP; Department of Radiation Oncology, Mount Sinai Health System, New York, New York, USA., Johansen S; Department of Life Sciences and Health, Oslo Metropolitan University, Faculty of Health Sciences, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway; Singapore institute of Technology, Health and Social Sciences, Singapore.
Publikováno v:
Journal of medical imaging and radiation sciences [J Med Imaging Radiat Sci] 2024 Jun; Vol. 55 (2), pp. 221-231. Date of Electronic Publication: 2024 Feb 29.
Autor:
Haakensen VD; Dept of Oncology, Oslo University Hospital, Oslo, Norway; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Öjlert ÅK; Dept of Oncology, Oslo University Hospital, Oslo, Norway; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Thunold S; Dept of Oncology, Oslo University Hospital, Oslo, Norway; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Farooqi S; Dept of Oncology, Oslo University Hospital, Oslo, Norway; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Nowak AK; Medical School of The University of Western Australia, Western Australia, Australia; National Centre for Asbestos-Related Diseases, University of Western Australia, Australia; Sir Charles Gairdner Hospital, Western Australia, Australia., Chin WL; National Centre for Asbestos-Related Diseases, University of Western Australia, Australia; Sir Charles Gairdner Hospital, Western Australia, Australia., Grundberg O; Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden; Dept of Molecular Medicine and Surgery, Karolinska Institute Stockholm, Sweden., Szejniuk WM; Clinical Cancer Research Center & Department of Oncology, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Cedres S; Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Dalen TS; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Lund-Iversen M; Dept of Pathology, Oslo University Hospital, Oslo, Norway., Bjaanæs M; Dept of Oncology, Oslo University Hospital, Oslo, Norway., Helland Å; Dept of Oncology, Oslo University Hospital, Oslo, Norway; Dept of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: aslaug.helland@medisin.uio.no.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113973. Date of Electronic Publication: 2024 Mar 01.
Autor:
Langberg CW; Faculty of Medicine, University of Oslo, Oslo, Norway., Horndalsveen H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Helland Å; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Haakensen VD; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jul 05; Vol. 13, pp. 1217424. Date of Electronic Publication: 2023 Jul 05 (Print Publication: 2023).
Autor:
Horndalsveen H; Department of Oncology, Oslo University Hospital, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway., Alver TN; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Department of Clinical Medicine, University of Oslo, Norway., Dalsgaard AM; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway., Rogg LV; Department of Oncology, Oslo University Hospital, Norway., Helbekkmo N; Department of Pulmonology, University Hospital of North Norway, Tromsø, Norway., Grønberg BH; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Norway., Halvorsen TO; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, Norway., Ramberg C; Department of Medical Physics, Oslo University Hospital, Norway., Haakensen VD; Department of Oncology, Oslo University Hospital, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway., Öjlert ÅK; Department of Oncology, Oslo University Hospital, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway., Bjaanaes MM; Department of Oncology, Oslo University Hospital, Norway., Helland Å; Department of Oncology, Oslo University Hospital, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Department of Clinical Medicine, University of Oslo, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Mar; Vol. 17 (3), pp. 487-498. Date of Electronic Publication: 2022 Nov 22.
Autor:
Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France and UVSQ, Paris Saclay, Versailles, France. Electronic address: nicolas.girard2@curie.fr., Bar J; Institute of Oncology, Sheba Medical Centre, Ramat Gan, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Garrido P; Medical Oncology Department, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain., Garassino MC; Department of Hematology/Oncology, The University of Chicago, Chicago, Illinois., McDonald F; Lung Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Mornex F; Department of Radiation Oncology, Centre Hospitalier Universitaire de Lyon, Lyon, France., Filippi AR; Radiation Oncology Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy., Smit HJM; Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, The Netherlands., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Field JK; Roy Castle Lung Cancer Research Programme, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom., Christoph DC; Department of Medical Oncology/Hematology, Evang. Kliniken Essen-Mitte, Evang. Huyssens-Stiftung Essen-Huttrop, Essen, Germany., Sibille A; Department of Pneumology and Allergology, Centre Hospitalier Universitaire de Liège, Liège, Belgium., Fietkau R; Department of Radiation Oncology, Universitätsklinikums Erlangen, Erlangen, Germany., Haakensen VD; Department of Oncology and Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Chouaid C; Service de Pneumologie, Centre Hospitalier Intercommunal de Créteil, Créteil, France., Markman B; Cabrini Hospital and Monash University, Melbourne, Victoria, Australia., Hiltermann TJN; University of Groningen, Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands., Taus A; Department of Medical Oncology, Hospital del Mar-CIBERONC, Barcelona, Spain., Sawyer W; AstraZeneca, Cambridge, United Kingdom., Allen A; AstraZeneca, Gaithersburg, Maryland., Chander P; AstraZeneca, Gaithersburg, Maryland., Licour M; AstraZeneca, Courbevoie, France., Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Feb; Vol. 18 (2), pp. 181-193. Date of Electronic Publication: 2022 Oct 25.
Autor:
Gulati G; Hjertemedisinsk avdeling, Oslo universitetssykehus, Ullevål, og, Forskning og innovasjonsavdelingen Akershus universitetssykehus, og, Universitetet i Oslo., Tjessem KH; Hjertemedisinsk avdeling, Oslo universitetssykehus, Ullevål., Horndalsveen H; Avdeling for kreftbehandling Oslo universitetssykehus, Ullevål, og, Avdeling for kreftgenetikk, Institutt for kreftbehandling, Oslo universitetssykehus, Radiumhospitalet., Halvorsen S; Hjertemedisinsk avdeling, Oslo universitetssykehus, Ullevål, og, Universitetet i Oslo., Haakensen VD; Avdeling for kreftbehandling Oslo universitetssykehus, Ullevål, og, Avdeling for kreftgenetikk, Institutt for kreftbehandling, Oslo universitetssykehus, Radiumhospitalet.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2022 Dec 12; Vol. 142 (18). Date of Electronic Publication: 2022 Dec 12 (Print Publication: 2022).
Autor:
Khadse A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Faculty of Technology, Natural Sciences and Maritime Sciences, Department of Natural Sciences and Environmental Health, University of South-Eastern Norway, Bø i Telemark, Norway., Haakensen VD; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Silwal-Pandit L; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Hamfjord J; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Micke P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Botling J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Brustugun OT; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Lingjærde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway., Kure EH; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Faculty of Technology, Natural Sciences and Maritime Sciences, Department of Natural Sciences and Environmental Health, University of South-Eastern Norway, Bø i Telemark, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Apr 29; Vol. 12, pp. 873532. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).